Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: An experimental serial cardiac magnetic resonance imaging study
- 6 November 2002
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (9) , 1695-1700
- https://doi.org/10.1016/s0735-1097(02)02375-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001
- Simvastatin inhibits noradrenaline‐induced hypertrophy of cultured neonatal rat cardiomyocytesBritish Journal of Pharmacology, 2001
- Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid LoweringArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2000
- The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nature Medicine, 2000
- Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cellsLife Sciences, 2000
- Neuroprotection mediated by changes in the endothelial actin cytoskeletonJournal of Clinical Investigation, 2000
- Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cellsEuropean Journal of Pharmacology, 1999
- Effects of chronic treatment with simvastatin on endothelial dysfunction in spontaneously hypertensive ratsJournal Of Hypertension, 1999
- Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase InhibitorsCirculation, 1998